1. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. Issue 12 (December 2021) Authors: DeMartino, Patrick; Haag, Meredith B.; Hersh, Alyssa R.; Caughey, Aaron B.; Roth, Joshua A. Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 12(2021) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. Issue 12 (December 2021) Authors: DeMartino, Patrick; Haag, Meredith B.; Hersh, Alyssa R.; Caughey, Aaron B.; Roth, Joshua A. Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer. (1st January 2021) Authors: Roth, Joshua A.; Yuan, Yong; Othus, Megan; Danese, Mark; Wagner, Samuel; Penrod, John R.; Ramsey, Scott D. Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting1. (8th April 2015) Authors: Roth, Joshua A.; Bradley, Katharine; Thummel, Kenneth E.; Veenstra, David L.; Boudreau, Denise Journal: Pharmacoepidemiology and drug safety Issue: Volume 24:Number 6(2015:Jun.) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost-Effectiveness of a 14-Gene Risk Score Assay to Target Adjuvant Chemotherapy in Early Stage Non-Squamous Non-Small Cell Lung Cancer. (7th April 2014) Authors: Roth, Joshua A.; Billings, Paul; Ramsey, Scott D.; Dumanois, Robert; Carlson, Josh J. Journal: Oncologist Issue: Volume 19:Number 5(2014) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer. (19th October 2015) Authors: Roth, Joshua A.; Ramsey, Scott D.; Carlson, Josh J. Journal: Oncologist Issue: Volume 20:Number 12(2015) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States. (2nd December 2018) Authors: Roth, Joshua A.; Sullivan, Sean D.; Lin, Vincent W.; Bansal, Aasthaa; Purdum, Anna G.; Navale, Lynn; Cheng, Paul; Ramsey, Scott D. Journal: Journal of medical economics Issue: Volume 21:Number 12(2018) Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost‐Effectiveness of a 14‐Gene Risk Score Assay to Target Adjuvant Chemotherapy in Early Stage Non‐Squamous Non‐Small Cell Lung Cancer. (7th April 2014) Authors: Roth, Joshua A.; Billings, Paul; Ramsey, Scott D.; Dumanois, Robert; Carlson, Josh J. Journal: Oncologist Issue: Volume 19:Number 5(2014) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cost‐Effectiveness of a Biopsy‐Based 8‐Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer. (19th October 2015) Authors: Roth, Joshua A.; Ramsey, Scott D.; Carlson, Josh J. Journal: Oncologist Issue: Volume 20:Number 12(2015) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). Issue 11 (November 2021) Authors: Roth, Joshua A.; Trivedi, Meghna S.; Gray, Stacy W.; Patrick, Donald L.; Delaney, Debbie M.; Watabayashi, Kate; Litwin, Paul; Shah, Parth; Crew, Katherine D.; Yee, Monica; Redman, Mary W.; Unger, Joseph M.; Papadimitrakopoulou, Vassiliki; Johnson, Judy; Kelly, Karen; Gandara, David; Herbst, Roy S... Journal: JCO oncology practice Issue: Volume 17:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗